| __timestamp | Corcept Therapeutics Incorporated | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 34916000 | 10337679 |
| Thursday, January 1, 2015 | 36949000 | 18187286 |
| Friday, January 1, 2016 | 45240000 | 24758063 |
| Sunday, January 1, 2017 | 62416000 | 23666957 |
| Monday, January 1, 2018 | 81289000 | 30099855 |
| Tuesday, January 1, 2019 | 100359000 | 64947625 |
| Wednesday, January 1, 2020 | 105326000 | 186363444 |
| Friday, January 1, 2021 | 122356000 | 272611040 |
| Saturday, January 1, 2022 | 152848000 | 358782000 |
| Sunday, January 1, 2023 | 184259000 | 409864000 |
Data in motion
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, Intra-Cellular Therapies, Inc. and Corcept Therapeutics Incorporated have taken different paths in optimizing these costs. From 2014 to 2023, Intra-Cellular Therapies saw a staggering increase in SG&A expenses, growing nearly 40 times from 2014 to 2023. Meanwhile, Corcept Therapeutics experienced a more moderate rise, with expenses increasing by approximately 5 times over the same period.
This divergence highlights contrasting strategies: Intra-Cellular Therapies may be investing heavily in growth and expansion, while Corcept Therapeutics appears to be maintaining a more controlled cost structure. As the biotech industry continues to evolve, these strategies will play a pivotal role in shaping each company's future success.
Who Optimizes SG&A Costs Better? Gilead Sciences, Inc. or Intra-Cellular Therapies, Inc.
Operational Costs Compared: SG&A Analysis of GSK plc and Intra-Cellular Therapies, Inc.
Intra-Cellular Therapies, Inc. vs Summit Therapeutics Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Intra-Cellular Therapies, Inc. and Bio-Techne Corporation
Cost Management Insights: SG&A Expenses for Intra-Cellular Therapies, Inc. and Ascendis Pharma A/S
Intra-Cellular Therapies, Inc. and TG Therapeutics, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Intra-Cellular Therapies, Inc. vs Verona Pharma plc
Intra-Cellular Therapies, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Geron Corporation Trends and Insights
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
Corcept Therapeutics Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Iovance Biotherapeutics, Inc.